Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Changsheng DengJianping Song

Abstract

Mass drug administration (MDA), with or without low-dose primaquine (PMQLD), is being considered for malaria elimination programs. The potential of PMQLD to block malaria transmission by mosquitoes must be balanced against liabilities of its use. Artemisinin-piperaquine (AP), with or without PMQLD, was administered in 3 monthly rounds across Anjouan Island, Union of Comoros. Plasmodium falciparum malaria rates, mortality, parasitemias, adverse events, and PfK13 Kelch-propeller gene polymorphisms were evaluated. Coverage of 85 to 93% of the Anjouan population was achieved with AP plus PMQLD (AP+PMQLD) in 2 districts (population 97164) and with AP alone in 5 districts (224471). Between the months of April-September in both 2012 and 2013, average monthly malaria hospital rates per 100000 people fell from 310.8 to 2.06 in the AP+PMQLD population (ratio 2.06/310.8 = 0.66%; 95% CI: 0.02%, 3.62%; P = .00007) and from 412.1 to 2.60 in the AP population (ratio 0.63%; 95% CI: 0.11%, 1.93%; P < .00001). Effectiveness of AP+PMQLD was 0.9908 (95% CI: 0.9053, 0.9991), while effectiveness of AP alone was 0.9913 (95% CI: 0.9657, 0.9978). Both regimens were well tolerated, without severe adverse events. Analysis of 52 malaria samples after MDA ...Continue Reading

References

Oct 2, 2003·Trends in Parasitology·Lorenz von Seidlein, Brian M Greenwood
Jun 29, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dapa A DialloSamia A Hurst
Oct 24, 2009·The Journal of Infectious Diseases·Lucy C OkellChris J Drakeley
Sep 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R D GoslingD Chandramohan
Nov 28, 2012·The Lancet Infectious Diseases·Nicholas J White
Dec 20, 2013·Nature·Frédéric ArieyDidier Ménard
Jul 31, 2014·The New England Journal of Medicine·David L SaundersUNKNOWN Royal Cambodian Armed Forces
Aug 20, 2015·Malaria Journal·Olivier MaillardLaurent Filleul
Sep 30, 2015·Antimicrobial Agents and Chemotherapy·Marylin Torrentino-MadametBruno Pradines
Feb 26, 2016·The Lancet Infectious Diseases·Brian Greenwood, Roger Tine
May 11, 2016·Bulletin de la Société de pathologie exotique·M ToybP Aubry
Jul 8, 2016·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·Said Abasse KassimAixia Ma
Aug 27, 2016·Parasite : Journal De La Société Française De Parasitologie·Nasserdine Papa MzeSouleymane Mboup
Nov 15, 2016·The Lancet Infectious Diseases·Nicholas J White
Sep 28, 2017·Malaria Journal·Ismaël ChakirRonan Jambou

❮ Previous
Next ❯

Citations

Sep 27, 2018·Antimicrobial Agents and Chemotherapy·Pere Millat-MartínezOriol Mitjà
Oct 12, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jennifer L Guler, Philip J Rosenthal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2022 Meta ULC. All rights reserved